(-)-epicatechin activation of endothelial cell endothelial nitric oxide synthase, nitric oxide, and related signaling pathways.
about
Timeline of History of Hypertension TreatmentAlteration of the systemic and microcirculation by a single oral dose of flavan-3-olsInward Rectifier K+ Currents Are Regulated by CaMKII in Endothelial Cells of Primarily Cultured Bovine Pulmonary Arteries(-)-Epicatechin Prevents Blood Pressure Increase and Reduces Locomotor Hyperactivity in Young Spontaneously Hypertensive Rats.Chocolate Consumption and Risk of Heart Failure: A Meta-Analysis of Prospective StudiesCell membrane mediated (-)-epicatechin effects on upstream endothelial cell signaling: evidence for a surface receptor.Cocoa, blood pressure, and vascular function.Deleterious effects of maternal ingestion of cocoa upon fetal ductus arteriosus in late pregnancy.(-)-Epicatechin induces calcium and translocation independent eNOS activation in arterial endothelial cells.Plant-derived flavanol (-)epicatechin mitigates anxiety in association with elevated hippocampal monoamine and BDNF levels, but does not influence pattern separation in mice.Dose-dependent increases in flow-mediated dilation following acute cocoa ingestion in healthy older adults.Intravenous (-)-epicatechin reduces myocardial ischemic injury by protecting mitochondrial function.Syringaresinol causes vasorelaxation by elevating nitric oxide production through the phosphorylation and dimerization of endothelial nitric oxide synthase.The effects of (-)-epicatechin on endothelial cells involve the G protein-coupled estrogen receptor (GPER).Chocolate consumption and risk of heart failure in the Physicians' Health StudyEpicatechin elicits MyoD-dependent myoblast differentiation and myogenic conversion of fibroblasts.Stimulatory effects of the flavanol (-)-epicatechin on cardiac angiogenesis: additive effects with exercise.Vasculoprotective Effects of Dietary Cocoa Flavanols in Patients on Hemodialysis: A Double-Blind, Randomized, Placebo-Controlled Trial.(-)-Epicatechin administration and exercising skeletal muscle vascular control and microvascular oxygenation in healthy ratsThe flavonoid luteolin induces nitric oxide production and arterial relaxation.(-)-Epicatechin-induced recovery of mitochondria from simulated diabetes: Potential role of endothelial nitric oxide synthase.Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy.Interplay of myosin phosphatase and protein phosphatase-2A in the regulation of endothelial nitric-oxide synthase phosphorylation and nitric oxide production.Flavanols and cardiovascular disease prevention.Modulation of metabolic syndrome-related inflammation by cocoa.Modulation of nitric oxide by flavonoids.Effects of a natural extract of Aronia Melanocarpa berry on endothelial cell nitric oxide production.Beneficial effects of dark chocolate on exercise capacity in sedentary subjects: underlying mechanisms. A double blind, randomized, placebo controlled trialCardiovascular Benefits of Dark Chocolate?Therapeutic uses of epicatechin in diabetes and cancer.Tea-induced improvement of endothelial function in humans: No role for epigallocatechin gallate (EGCG).Effects of (-)-epicatechin and derivatives on nitric oxide mediated induction of mitochondrial proteins.Cocoa flavanols: effects on vascular nitric oxide and blood pressure.(-)-Epicatechin-induced calcium independent eNOS activation: roles of HSP90 and AKT.Endothelium/nitric oxide mechanism mediates vasorelaxation and counteracts vasoconstriction induced by low concentration of flavanols.(-)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle.(-)-Epicatechin reduces blood pressure and improves vasorelaxation in spontaneously hypertensive rats by NO-mediated mechanism.(-)-Epicatechin stimulates mitochondrial biogenesis and cell growth in C2C12 myotubes via the G-protein coupled estrogen receptor.(-)-Epicatechin-induced relaxation of isolated human saphenous vein: Roles of K+ and Ca2+ channels.Synthesis of novel (-)-epicatechin derivatives as potential endothelial GPER agonists: Evaluation of biological effects.
P2860
Q26768219-91C6B52F-E4B5-4029-A3FD-C5FA053D65EEQ27340167-42B1E537-0423-4E21-92FD-2C0660EDCF26Q28551706-55BAD53C-4F10-43B3-90A8-CC24D63180F0Q30828932-F47D5E0F-89D2-404F-9C8E-09AB9E925BC6Q33616957-75CF568D-C27C-43CC-A423-28BC836BAADAQ34150321-3CB46C5D-9D3A-4A4B-8955-C9AA602ABCFCQ34280329-6E8EDAC3-28FA-4489-BD40-1AB5F37B8A2DQ34755550-A3069675-6FA2-44AF-9655-E494C7379700Q34782177-7D1F95AC-2560-49B2-B81E-0D8DA083288FQ35034790-25793B2C-2226-450C-B072-E062652BF70AQ35601663-F7F5B6F1-AF5D-4C76-89B4-86115AAD43EAQ35862403-C851EC96-9D2C-4EF0-B433-98290F495CFCQ35865615-3A7B2CA1-A517-420B-B79C-31FBE996DB69Q36014772-998273B0-D30D-42DC-84A1-CEA87F81D670Q36283980-FF5CC932-5426-4470-97E4-6703BC814D34Q36338261-27B7E26F-2DE4-4397-B715-F11439DCD6EAQ36392897-71B3D115-1BD4-48A9-9DFF-929845477F95Q36432925-11E236AF-9F33-4D7E-B6F9-8281F742D5E3Q36528059-FFF175D2-1C9D-4423-9A28-056E3FC99168Q37101489-CEC4ED65-8DD0-4220-B5FB-0FCAE28A08FBQ37410829-4BF4E42C-E116-4CCA-819E-BA1626C55966Q37592492-7B6277AC-00F4-4C1D-9EB1-0F50B4B1FFBCQ37704798-1AFC93ED-C4B0-4DD7-8421-0A39933EA7A4Q37790217-3973B908-0844-40B7-A031-7E4D11F4E80FQ38103512-F5C645BB-0528-4AC3-9C94-5CDFF00C082AQ38217861-81B19F97-2070-4298-99E6-0717CF2E0B16Q38822387-756920A9-8AC9-4695-9F52-B5F89FED3167Q39523876-2104E014-F62D-4924-A1F7-8C11252CAEA6Q40443322-17FF00EA-4157-4313-AF4B-DB1D66CEDA13Q41469702-FB454FE3-D14C-488B-A99B-D2075439C420Q42212385-2BEE4703-B209-49EA-AA40-C4347D21B1CCQ42551085-3922AC58-73ED-462C-AAF7-5119F8F2246BQ42573612-7206D551-FF70-4FEA-950F-85BC5B1C1545Q42928300-96DB3AC7-6BD6-4D66-94E0-5E27FB9C55C5Q44373264-942E312E-FF78-4030-A5C8-9EFAA71AB455Q45790850-FCF89FC3-F86D-4E1E-9ADF-420828B1A146Q46971267-6AA9080F-AFCA-4FD8-9C17-604E6F5AC108Q47651479-03438379-0553-4C0D-ACBE-9DE4598B4DC4Q48201076-6B113722-2979-43E6-9E52-43DE945AA29EQ48514610-C32B8FBA-855B-4641-BB4F-37EEB4044194
P2860
(-)-epicatechin activation of endothelial cell endothelial nitric oxide synthase, nitric oxide, and related signaling pathways.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
(-)-epicatechin activation of ...... nd related signaling pathways.
@en
type
label
(-)-epicatechin activation of ...... nd related signaling pathways.
@en
prefLabel
(-)-epicatechin activation of ...... nd related signaling pathways.
@en
P2093
P2860
P1433
P1476
(-)-epicatechin activation of ...... nd related signaling pathways.
@en
P2093
Francisco Villarreal
Israel Ramirez-Sanchez
Lisandro Maya
P2860
P304
P356
10.1161/HYPERTENSIONAHA.109.147892
P407
P577
2010-04-19T00:00:00Z